Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD)

Historical Holders from Q2 2016 to Q1 2025

Symbol
CLSD on Nasdaq
CUSIP
185063104
Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
77M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
9.44M
Holdings value
$8.97M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
45
Number of buys
18
Number of sells
-22
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
WHITMORE BRADFORD T 8.6% $5.99M 6.52M WHITMORE BRADFORD T Dec 31, 2024
Wiles Stephen Boyd 5.2% $3.67M 4M Stephen Boyd Wiles Mar 31, 2025

Institutional Holders of Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 167K $154K +$13.8K $0.92 4
2024 Q4 9.44M $8.97M -$10.8M $0.95 45
2024 Q3 10.1M $22.7M -$4.79M $1.27 49
2024 Q2 13.8M $17.9M -$2.36M $1.30 49
2024 Q1 15.5M $23.8M +$12M $1.53 53
2023 Q4 7.75M $9.06M +$29.1K $1.17 46
2023 Q3 7.84M $6.82M -$748K $0.87 45
2023 Q2 8.59M $9.62M -$244K $1.12 53
2023 Q1 8.73M $9.08M -$468K $1.04 48
2022 Q4 9.12M $10.2M -$825K $1.12 51
2022 Q3 12.1M $13.6M -$1.77M $1.13 46
2022 Q2 13.7M $20.1M -$4.09M $1.47 47
2022 Q1 16.4M $37.5M -$12.6M $2.29 58
2021 Q4 21M $57.8M -$5.52M $2.75 63
2021 Q3 20.3M $122M +$4.44M $6.00 64
2021 Q2 19.7M $95.8M -$3.81M $4.87 53
2021 Q1 16M $39.5M +$8.5M $2.47 50
2020 Q4 12.6M $34.4M +$4.19M $2.74 38
2020 Q3 12M $18.4M -$33.8K $1.54 39
2020 Q2 11.8M $22.1M +$524K $1.88 43
2020 Q1 11.5M $19.5M +$5.91M $1.70 38
2019 Q4 7.94M $23M +$2.76M $2.90 44
2019 Q3 6.99M $4.4M +$1.25M $0.63 28
2019 Q2 4.51M $4.38M -$1.79M $0.97 42
2019 Q1 6.12M $8.45M -$8.18M $1.38 53
2018 Q4 8.62M $9.22M -$28.7M $1.07 63
2018 Q3 18.5M $114M -$22.8M $6.15 85
2018 Q2 20.4M $218M +$7.95M $10.69 83
2018 Q1 19.6M $211M +$82.1M $10.73 78
2017 Q4 12.3M $86.3M -$5.59M $7.00 51
2017 Q3 13.1M $114M -$1.67M $8.74 48
2017 Q2 13.3M $121M +$11M $9.11 51
2017 Q1 12M $95.2M +$3.41M $7.94 57
2016 Q4 11.8M $106M +$35.2M $8.94 59
2016 Q3 7.93M $138M +$10.6M $17.35 29
2016 Q2 7.53M $52.7M +$52.7M $7.01 16